ReviewCancers2019

Does an Alternative Sunitinib Dosing Schedule Really Improve Survival Outcomes over a Conventional Dosing Schedule in Patients with Metastatic Renal Cell Carcinoma? An Updated Systematic Review and Meta-Analysis.

Doo Yong Chung et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.